Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 47 (NPM1P47) is a genomic sequence resembling the functional NPM1 gene, but considered a pseudogene—meaning it does not code for a functional protein and has no established biological, pharmacological, or pathological role. NPM1 pseudogenes may exist due to duplication or retrotransposition events and chiefly serve as evolutionary remnants. While the parent gene *NPM1* encodes a nucleolar phosphoprotein implicated in cancer and cell proliferation[1][2], pseudogenes like NPM1P47 are not targets for pharmacological intervention and are usually ignored in drug development and translational biology. If the intention was to inquire about the canonical functional NPM1 gene (not the pseudogene NPM1P47), then NPM1 is a well-established therapeutic target in oncology; however, NPM1P47 itself is not an actionable target[1][2].
Not applicable; pseudogenes like NPM1P47 have no described mechanisms for drug action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 47 (NPM1P47).